XML 137 R14.htm IDEA: XBRL DOCUMENT v3.25.1
Accrued Expenses and Other Current Liabilities
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Accrued Expenses and Other Current Liabilities [Abstract]    
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

8. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES 

 

Accrued expenses and other current liabilities consisted of the following as of the periods indicated:

 

   March 31,   December 31, 
   2025   2024 
Accrued research and development expense  $1,799,583   $1,799,583 
Accrued directors and officers (owners) compensation   991,821    1,025,867 
Cash portion of the Lind Note repayments   227,284    127,759 
Accrued compensation and employee benefits   140,252    126,106 
Others   617,879    557,866 
Total  $3,826,819   $3,509,422 

8. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES 

 

Accrued expenses and other current liabilities consisted of the following as of the periods indicated:

 

   December 31,   December 31, 
   2024   2023 
Accrued research and development expense  $1,799,583   $1,799,583 
Accrued directors and officers (owners) compensation   1,025,867    1,018,253 
Accrued royalties   255,592    274,028 
Accrued compensation and employee benefits   126,106    29,138 
Others   302,274    427,350 
Total  $3,509,422   $3,548,352